NasdaqCM - Nasdaq Real Time Price USD
PolyPid Ltd. (PYPD)
Tune into earnings calls Now streaming directly on quote pages.
2.9276
+0.0276
+(0.96%)
As of 1:11:15 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-21,963
-21,963
-17,236
-34,317
-32,386
Investing Cash Flow
-330
-330
3,804
16,575
36,900
Financing Cash Flow
32,416
32,416
9,976
16,428
1,034
End Cash Position
15,809
15,809
5,686
9,142
10,456
Income Tax Paid Supplemental Data
3
3
18
8
0
Interest Paid Supplemental Data
950
950
1,038
734
0
Capital Expenditure
-76
-76
-196
-1,767
-2,993
Issuance of Capital Stock
35,863
35,863
8,723
4,423
0
Issuance of Debt
0
0
0
11,711
0
Repayment of Debt
-3,322
-3,322
-2,618
-402
0
Free Cash Flow
-22,039
-22,039
-17,432
-36,084
-35,379
12/31/2021 - 6/26/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CNTB Connect Biopharma Holdings Limited
0.7512
-3.94%
GRCE Grace Therapeutics, Inc.
2.7500
+0.73%
APLT Applied Therapeutics, Inc.
0.4902
+1.03%
XFOR X4 Pharmaceuticals, Inc.
3.0550
-5.71%
ALGS Aligos Therapeutics, Inc.
5.87
+5.58%
VNDA Vanda Pharmaceuticals Inc.
3.9600
+1.02%
MURA Mural Oncology plc
2.4900
-2.73%
MIST Milestone Pharmaceuticals Inc.
1.1550
-1.28%
FDMT 4D Molecular Therapeutics, Inc.
3.1300
0.00%
LPCN Lipocine Inc.
3.5401
+12.03%